|
1
|
Ren J, Xu Y, Huang Q, Yang J, Yang M, Hu K
and Wei K: Chabamide induces cell cycle arrest and apoptosis by the
Akt/MAPK pathway and inhibition of P-glycoprotein in K562/ADR
cells. Anticancer Drugs. 26:498–507. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Li H, Guo K, Wu C, Shu L, Guo S, Hou J,
Zhao N, Wei L, Man X and Zhang L: Controlled and targeted drug
delivery by a UV-responsive liposome for overcoming
chemo-resistance in non-hodgkin lymphoma. Chem Biol. Drug Des.
86:783–794. 2015.
|
|
3
|
Nabekura T, Hiroi T, Kawasaki T and Uwai
Y: Effects of natural nuclear factor-kappa B inhibitors on
anticancer drug efflux transporter human P-glycoprotein. Biomed
Pharmacother. 70:140–145. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wen X, Zhang HD, Zhao L, Yao YF, Zhao JH
and Tang JH: Ginsenoside Rh2 differentially mediates microRNA
expression to prevent chemoresistance of breast cancer. Asian Pac J
Cancer. 16:1105–1109. 2015. View Article : Google Scholar
|
|
5
|
Bao W, Zhu F, Duan Y, Yang Y and Cai H:
HtrA1 resensitizes multidrug-resistant hepatocellular carcinoma
cells by targeting XIAP. Biomed Pharmacother. 70:97–102. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang Z, Yang L, Xia Y, Guo C and Kong L:
Icariin enhances cytotoxicity of doxorubicin in human
multidrug-resistant osteosarcoma cells by inhibition of ABCB1 and
down-regulation of the PI3K/Akt pathway. Biol Pharm Bull.
38:277–284. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Song YN, Guo XL, Zheng BB, Liu XY, Dong X,
Yu LG and Cheng YN: Ligustrazine derivate DLJ14 reduces multidrug
resistance of K562/A02 cells by modulating GSTp activity. Toxicol
In Vitro. 25:937–943. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ma J, Wang T, Guo R, Yang X, Yin J, Yu J,
Xiang Q, Pan X, Tang H and Lei X: Involvement of miR-133a and
miR-326 in ADM resistance of HepG2 through modulating expression of
ABCC1. J Drug Target. 25:519–524. 2015. View Article : Google Scholar
|
|
9
|
Yang X, Iyer AK, Singh A, Choy E, Hornicek
FJ, Amiji MM and Duan Z: MDR1 siRNA loaded hyaluronic acid-based
CD44 targeted nanoparticle systems circumvent paclitaxel resistance
in ovarian cancer. Sci Rep. 5:85092015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fantappiè O, Sassoli C, Tani A, Nosi D,
Marchetti S, Formigli L and Mazzanti R: Mitochondria of a human
multidrug-resistant hepatocellularcarcinoma cell line
constitutively express inducible nitric oxide synthase in the inner
membrane. J Cell Mol Med. 19:1410–1417. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xu X, Zhang Y, Li W, Miao H, Zhang H, Zhou
Y, Li Z, You Q, Zhao L and Guo Q: Wogonin reverses multi-drug
resistance of human myelogenous leukemia K562/A02 cells via
downregulation of MRP1 expression by inhibiting Nrf2/ARE signaling
pathway. Biochem Pharmacol. 92:220–234. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Han L, Wang Y, Guo X, Zhou Y, Zhang J,
Wang N, Jiang J, Ma F and Wang Q: Downregulation of MDR1 Gene by
cepharanthine hydrochloride is related to the activation of
c-Jun/JNK in K562/ADR cells. Biomed Res Int. 2014:1643912014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Seki E, Brenner DA and Karin M: A liver
full of JNK: Signaling in regulation of cell function and disease
pathogenesis, and clinical approaches. Gastroenterology.
143:307–320. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang W, Chen BA, Jin JF, He YJ and Niu
YQ: Involvement of c-Jun N-terminal kinase in reversal of multidrug
resistance of human leukemia cells in hypoxia by
5-bromotetrandrine. Leuk Lymphoma. 54:2506–2516. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhu MM, Tong JL, Xu Q, Nie F, Xu XT, Xiao
SD and Ran ZH: Increased JNK1 Signaling pathway is responsible for
ABCG2-mediated multidrug resistance in human colon cancer. PLoS
One. 7:e417632012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhan X, Feng X, Kong Y, Chen Y and Tan W:
JNK signaling maintains the mesenchymal properties of multi-drug
resistant human epidermoid carcinoma KB cells through snail and
twist1. BMC Cancer. 13:1802013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhou J, Liu M, Aneja R, Chandra R, Lage H
and Joshi HC: Reversal of P-glycoprotein-mediated multidrug
resistance in cancer cells by the c-Jun NH2-terminal kinase. Cancer
Res. 66:445–452. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lu MK, Shih YW, Chien Chang TT, Fang LH,
Huang HC and Chen PS: α-Solanine inhibits human melanoma cell
migration and invasion by reducing matrix metalloproteinase-2/9
activities. Biol Pharm Bull. 33:1685–1691. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sun H, Lv C, Yang L, Wang Y, Zhang Q, Yu
S, Kong H, Wang M, Xie J, Zhang C and Zhou M: Solanine induces
mitochondria-mediated apoptosis in human pancreatic cancer cells.
Biomed Res Int. 2014:8059262014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kenny OM, McCarthy CM, Brunton NP, Hossain
MB, Rai DK, Collins SG, Jones PW, Maguire AR and O'Brien NM:
Anti-inflammatory properties of potato glycoalkaloids in stimulated
Jurkat and Raw 264.7 mouse macrophages. Life Sci. 92:775–782. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lv C, Kong H, Dong G, Liu L, Tong K, Sun
H, Chen B, Zhang C and Zhou M: Antitumor Efficacy of α-Solanine
against pancreatic cancer in vitro and in vivo. PLoS One.
9:e878682014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gao SY, Wang QJ and Ji YB: Effect of
solanine on the membrane potential of mitochondria in HepG2 cells
and [Ca2+]i in the cells. World J Gastroenterol. 12:3359–3367.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ji YB, Gao SY, Ji CF and Zou X: Induction
of apoptosis in HepG2 cells by solanine and Bcl-2 protein. J
Ethnopharmacol. 115:194–202. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shen KH, Liao AC, Hung JH, Lee WJ, Hu KC,
Lin PT, Liao RF and Chen PS: α-Solanine inhibits invasion of human
prostate cancer cell by suppressing epithelial-mesenchymal
transition and MMPs expression. Molecules. 19:11896–11914. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kang H, Jeong HD and Choi HY: The
chloroform fraction of Solanum nigrum suppresses nitric oxide and
tumor necrosis factor-α in LPS-stimulated mouse peritoneal
macrophages through inhibition of p38, JNK and ERK1/2. Am J Chin
Med. 39:1261–1273. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang JY, Jia XH, Xing HY, Li YJ, Fan WW,
Li N and Xie SY: Inhibition of Forkhead box protein M1 by
thiostrepton increases chemosensitivity to doxorubicin in T-cell
acute lymphoblastic leukemia. Mol Med Rep. 12:1457–1464. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sengupta A, Banerjee D, Chandra S, Banerji
SK, Ghosh R, Roy R and Banerjee S: Deregulation and cross talk
among Sonic hedgehog, Wnt, Hox and Notch signaling in chronic
myeloid leukemia progression. Leukemia. 21:949–955. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Abdallah HM, Al-Abd AM, El-Dine RS and
El-Halawany AM: P-glycoprotein inhibitors of natural origin as
potential tumor chemo-sensitizers: A review. J Adv Res. 6:45–62.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Friedman M: Chemistry and anticarcinogenic
mechanisms of glycoalkaloids produced by eggplants, potatoes, and
tomatoes. J Agric Food Chem. 63:3323–3337. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Friedman M, Lee KR, Kim HJ, Lee IS and
Kozukue N: Anticarcinogenic effects of glycoalkaloids from potatoes
against human cervical, liver, lymphoma, and stomach cancer cells.
J Agric Food Chem. 53:6162–6169. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang XB, Wang SS, Zhang QF, Liu M, Li HL,
Liu Y, Wang JN, Zheng F, Guo LY and Xiang JZ: Inhibition of
tetramethylpyrazine on P-gp, MRP2, MRP3 and MRP5 in multidrug
resistant human hepatocellular carcinoma cells. Oncol Rep.
23:211–215. 2010.PubMed/NCBI
|
|
32
|
Yan F, Wang XM, Liu ZC, Pan C, Yuan SB and
Ma QM: JNK1, JNK2, and JNK3 are involved in P-glycoprotein-mediated
multidrug resistance of hepatocellular carcinoma cells.
Hepatobiliary Pancreat Dis Int. 9:287–295. 2010.PubMed/NCBI
|
|
33
|
Tang PM, Zhang DM, Xuan NH, Tsui SK, Waye
MM, Kong SK, Fong WP and Fung KP: Photodynamic therapy inhibits
p-glycoprotein mediated multidrug resistance via JNK activation in
human hepatocellular carcinoma using the photosensitizer
pheophorbide a. Mol Cancer. 8:562009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Comerford KM, Cummins EP and Taylor CT:
c-Jun NH2-terminal kinase activation contributes to
hypoxia-inducible factor 1alpha-dependent P-glycoprotein expression
in hypoxia. Cancer Res. 64:9057–9061. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ronaldson PT, Ashraf T and Bendayan R:
Regulation of multidrug resistance protein 1 by tumor necrosis
factor α in cultured glial cells: Involvement of nuclear
factor-kappaB and c-Jun N-terminal kinase signaling pathways. Mol
Pharmacol. 77:644–659. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Findlay VJ, Townsend DM, Saavedra JE,
Buzard GS, Citro ML, Keefer LK, Ji X and Tew KD: Tumor cell
responses to a novel glutathione S-transferase-activated nitric
oxide-releasing prodrug. Mol Pharmacol. 65:1070–1079. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Cripe LD, Gelfanov VM, Smith EA, Spigel
DR, Phillips CA, Gabig TG, Jung SH, Fyffe J, Hartman AD, Kneebone
P, et al: Role for c-jun N-terminal kinase in treatment-refractory
acute myeloid leukemia (AML): Signaling to multidrug-efflux and
hyperproliferation. Leukemia. 16:799–812. 2002. View Article : Google Scholar : PubMed/NCBI
|
